| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 22, 2018Virtual Press Office and PR Newswire: General Trade show news
Company invites individual and institutional investors as well as advisors to log on to VirtualInvestorConferences.com to view presentation EUGENE, Ore., Oct. 22, 2018 /PRNewswire/ -- Arcimoto, Inc.®
-
Oct 22, 2018Virtual Press Office and PR Newswire: General Trade show news
Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today presented clinical data from the PROPEL study of PTG-100, the Company's oral, gut-restricted alpha-4-beta-7 integrin antagonist peptide for the...
-
Oct 22, 2018Unlock a new future in financial crime compliance through transformative digital risk identificationVirtual Press Office and PR Newswire: General Trade show news
Today at Sibos, the world's premier financial services event, LexisNexis Risk Solutions unveiled innovative product initiatives that will transform the way banks and companies in other industries...
-
Oct 22, 2018Virtual Press Office and PR Newswire: General Trade show news
Oracle OpenWorld 2018 will be the launch pad for RapidBlocksTM, the revolutionary Blockchain SaaS tool by AuraBlocks. The AuraBlocks team, along with other industry leaders, will be presenting...
-
Oct 22, 2018Virtual Press Office and PR Newswire: General Trade show news
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the presentation of data from two clinical trials for PEGPH20 (pegvorhyaluronidase alfa) in patients with advanced pancreas and...
